Balanced Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Sell
301
-10
-3% -$10.2K 0.11% 60
2026
Q1
$286K Sell
311
-195
-39% -$198K 0.1% 64
2025
Q4
$417K Buy
506
+1
+0.2% +$956 0.15% 51
2025
Q3
$392K Hold
505
0.17% 49
2025
Q2
$374K Hold
505
0.16% 50
2025
Q1
$417K Buy
505
+1
+0.2% +$832 0.2% 47
2024
Q4
$409K Sell
504
-32
-6% -$26.5K 0.18% 49
2024
Q3
$475K Hold
536
0.21% 46
2024
Q2
$490K Sell
536
-176
-25% -$141K 0.22% 49
2024
Q1
$550K Sell
712
-66
-8% -$47K 0.24% 43
2023
Q4
$454K Buy
+778
New +$454K 0.24% 46

Other funds holding LLY

Balanced Wealth Group's LLY Position: Q2 2026 in Review

Balanced Wealth Group reduced its Eli Lilly (LLY) stake by 3.2% in Q2 2026, selling an estimated $10.2K and leaving 301 shares worth $361K. The position accounts for 0.11% of the portfolio, ranked #60.

Balanced Wealth Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $550K in Q1 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Balanced Wealth Group held 301 shares of Eli Lilly worth $361K as of Q2 2026.
  • Balanced Wealth Group sold 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.11% of Balanced Wealth Group's portfolio in Q2 2026, its #60 holding.
  • Balanced Wealth Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Balanced Wealth Group's Eli Lilly position peaked at $550K in Q1 2024.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Balanced Wealth Group's 13F filing for Q2 2026, filed 10 Aug 2026.